Nexus recaps with Alaris minority stake to fund next growth phase

What's the deal? Nexus EnterprisesDealroom has a profile for this one. Try Dealroom →, a Schertz, Texas-based clinical review and dispute resolution provider, has completed a minority investment from Alaris Equity PartnersDealroom has a profile for this one. Try Dealroom →. The recapitalization gives Nexus's owners liquidity while bringing in a long-term capital partner.

What does Nexus do? Founded in 2009, it delivers clinical and specialty review services across the healthcare, workers' compensation, and government sectors. The company combines board-certified clinical expertise, evidence-based guidelines, and proprietary technology to serve insurers, third-party administrators, employers, managed care organizations, and government entities.

What's the endgame? The deal frees up resources to invest in people, technology, and capabilities without changing leadership. "Their flexible, partnership-oriented approach provides us with additional resources to invest in our people, technology and capabilities while preserving the culture and leadership that have driven Nexus' success," said founder and chief executive officer Ed Bolton.

Who's backing it? Alaris takes a minority position rather than control. "Nexus has built a high-quality business in the US healthcare dispute resolution industry, supported by an experienced ownership and management team," said Steve King, Alaris president and chief executive officer.

Behind the deal: Ernst & Young Capital Advisors served as financial advisor to Nexus, with Godfrey & Kahn as legal counsel and Cool Cat Technologies as transaction advisor.

The signal: Minority recapitalizations let founders cash out partially while keeping control — a middle path between selling outright and going it alone. For Alaris, the bet is on steady demand for clinical review and dispute resolution across US healthcare.

Image credit: Generated with Gemini